In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

Hanmi Pharmaceutical develops obesity drugs to increase muscle while reducing fat Hanmi Pharmaceutical pioneers innovative ...

Village Health Clubs & Spas dietitian Jamie Miller shares the top foods that naturally provide your body with GLP-1 without ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

The demand for semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA) commonly known under the brand names Ozempic and Wegovy, has surged in recent years, especially for weight loss. It ...

Semaglutide and tirzepatide are both glucagon-like peptide-1 receptor agonists ... he thinks about buying a box for his family. “Food noise is fueled significantly by our environment and ...

Developed by Novo Nordisk, semaglutide mimics glucagon-like peptide-1 (GLP-1 ... Ozempic acting on the GLP-1 receptors in your brain means it can reduce cravings and enhance satisfaction ...

The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...